Pharvaris (PHVS) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

PHVS Pharvaris

Watchlist

16.250
-0.160-0.98%

Trading Jan 14 12:16 ET

881.29MMarket Cap-6.10P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Pharvaris | 6-K: Report of foreign private issuer (related to financial reporting)
SECJan 13 07:27 ET · Announcements
Pharvaris Initiates Phase 3 Studies for Deucrictibant in Hereditary and Acquired Angioedema, Plans Strategic Developments for 2025
Quiver QuantitativeJan 13 07:01 ET
Express News | Pharvaris NV - Estimates Cash Runway Into 3Q2026
ReutersJan 13 06:50 ET
Express News | Pharvaris Outlines 2025 Strategic Priorities
ReutersJan 13 06:50 ET
Analysts Conflicted on These Healthcare Names: Pharvaris (PHVS) and Stevanato Group (STVN)
TipRanksJan 6 08:20 ET · Ratings
Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Ascendis Pharma (ASND) and BioNTech SE (BNTX)
TipRanksJan 2 08:10 ET · Ratings

Comments

70617300

Aug 15, 2024 08:18

Oppenheimer analyst Jeff Jones maintains $Pharvaris (PHVS.US)$ with a buy rating, and maintains the target price at $38.
According to TipRanks data, the analyst has a success rate of 36.7% and a total average return of 6.4% over the past year.

Alvinnnnnnngenius

Dec 6, 2023 05:50

$Pharvaris (PHVS.US)$ Pharvaris Announces Positive Top-line Phase 2 Data from the CHAPTER-1 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks

BioPharm Insight US

Dec 12, 2022 10:20

Columns Weekly FDA Drug Pipeline Calendar (Dec 12 - Dec 17)

Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week.
$Amgen (AMGN.US)$ Inc. is in advanced talks to buy drug company $Horizon Therapeutics (HZNP.US)$, according to people familiar with the matter, in a takeover likely to be valued at well over $20 billion and mark the largest healthcare merger of the year.
$ROCHESTER RESOURCES LTD (RCTFF.US)$Holding AG presented new data from a ...